Share

July 30, 2013; 81 (5) Contemporary Issues

Supply and demand analysis of the current and future US neurology workforce

Timothy M. Dall, Michael V. Storm, Ritashree Chakrabarti, Oksana Drogan, Christopher M. Keran, Peter D. Donofrio, Victor W. Henderson, Henry J. Kaminski, James C. Stevens, Thomas R. Vidic
First published April 17, 2013, DOI: https://doi.org/10.1212/WNL.0b013e318294b1cf
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
4641

Share

Article Information

vol. 81 no. 5 470-478
DOI: 
https://doi.org/10.1212/WNL.0b013e318294b1cf
PubMed: 
23596071
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received February 1, 2013
  • Accepted in final form March 29, 2013
  • First Published April 17, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Timothy M. Dall, MS,
    2. Michael V. Storm, BA,
    3. Ritashree Chakrabarti, PhD,
    4. Oksana Drogan, MS,
    5. Christopher M. Keran, BA,
    6. Peter D. Donofrio, MD,
    7. Victor W. Henderson, MD, MS,
    8. Henry J. Kaminski, MD,
    9. James C. Stevens, MD and
    10. Thomas R. Vidic, MD
  1. Timothy M. Dall, MS,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. ISRN Economics, Editorial Board Member since 2011.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. IHS Global Inc.

    Consultancies:

    1. Provides consulting services to federal and state governments, professional and trade organizations, pharmaceutical companies, and hospital systems.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Novo Nordisk

    Research Support, Government Entities:

    1. Bureau of Health Professions, Health Resources and Services Administration

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) American Academy of Neurology (2) American Diabetes Association (3) Pharmaceutical Research and Manufacturers of America (4) American Orthopedic Association (5) American Association of Orthopedic Surgeons (6) Physician Assistant Education Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Michael V. Storm, BA,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. IHS Global Inc., Consultant for Life Sciences

    Consultancies:

    1. Provides consulting services to federal and state governments, professional and trade organizations, pharmaceutical companies, and hospital systems.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Novo Nordisk.

    Research Support, Government Entities:

    1. Bureau of Health Professions, Health Resources and Services Administration

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) American Academy of Neurology, (2) American Diabetes Association, (3) Pharmaceutical Research and Manufacturers of America, (4) American Orthopedic Association, (5) American Association of Orthopedic Surgeons, (6) Physician Assistant Education Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Ritashree Chakrabarti, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. IHS Global Inc, Consultant for Life Sciences

    Consultancies:

    1. Providing consulting services to federal and state governments, professional and trade organizations, pharmaceutical companies, and hospital systems.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Novo Nordisk

    Research Support, Government Entities:

    1. (1) American Academy of Neurology, (2) American Diabetes Association, (3) Pharmaceutical Research and Manufacturers of America, (4) American Orthopedic Association, (5) American Association of Orthopedic Surgeons, (6) Physician Assistant Education Association

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Oksana Drogan, MS,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Salaried employee of the American Academy of Neurology

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Christopher M. Keran, BA,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. American Academy of Neurology, Senior Director Member Insights.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Peter D. Donofrio, MD,
    7. Scientific Advisory Boards:

    1. CSL Behring Baxter

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Talecris Pharmceuticals

    Editorial Boards:

    1. Muscle & Nerve, editorial board, 20008-2013

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Knopp Pharmaceuticals

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Expert witness for defendent-Pfizer

  7. Victor W. Henderson, MD, MS,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1. American Academy of Neurology, travel reimbursement. 2. International Menopause Society, travel reimbursement. 3. National Institutes of Health, travel reimbursement.

    Editorial Boards:

    1. Current editorial advisory board member without compensation: American Journal of Alzheimer's Disease and Other Dementias (since 1997); Climacteric (since 1998); Cognitive and Behavioral Neurology (since 2003); Menopause (since 2002); Journal of Steroid Biochemistry and Molecular Biology (since 2011); Menopause International (since 2007)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Stanford University

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Dr. Henderson receives honoraria for NIH study section participation.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. National Insitutes of Health, R01AG034639, PI, 2009- present. 2. National Insitutes of Health, N01-WH042109, co- investigator, 2008- present. 3. National Insitutes of Health, R01-AG023038, PI, 2005- 2011.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Henry J. Kaminski, MD,
    9. Scientific Advisory Boards:

    1. 1) Commercial, Cytokinetics DSMB-study sponsored by the NIH 2) Non-Profit Entity, EPITOME Study-Food and Drug Administration, DSMB

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Experimental Neurology, Editorial Board Member, 2013-

    Patents:

    1. Patent pending, Targeted therapy of complement inhibitor to neuromuscular junction

    Publishing Royalties:

    1. Myasthenia Gravis and Related Disorders, 2010, Springer Neuromuscular Disorders in Clinical Practice, 2001, Elsevier

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Varleigh Limited 2. GlaxoSmithKline 3. BayHill Therapeutics 4. Cytokinetics

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Mazorx Corporation

    Research Support, Government Entities:

    1. National Institutes of Health, R01 EY-015306, PI, 2004-2009 National Institutes of Health, R24 EY14837, PI, 2003-2010 National Institutes of Health, R01 NS42685, PI, 2005-2014

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. James C. Stevens, MD and
    10. Scientific Advisory Boards:

    1. 1)Biogen-Idec Scientific Advisory Board 2)Genzyme Scientific Advisory Board 3)Teva Scientific Advisory Board

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1)Biogen-Idec speaker/lecturer 2) Genzyme speaker/lecturer

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. 1)Biogen-Idec 2)Genzyme

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Sanofi-Aventis, Biogen-Idec, Teva

    Research Support, Government Entities:

    1. NINDS (POINT/ATTACH-II studies, co-investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Thomas R. Vidic, MD
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. stipend for servicing as officer of Indiana State Medical Assn

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. forest and novartis

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From IHS Healthcare & Pharma (T.M.D., M.V.S., R.C.), Washington, DC; American Academy of Neurology (O.D., C.M.K.), Minneapolis, MN; Vanderbilt University Medical Center (P.D.D.), Nashville, TN; Departments of Health Research & Policy and Neurology & Neurological Sciences (V.W.H.), Stanford University, Stanford, CA; Department of Neurology (H.J.K.), George Washington University, Washington, DC; Fort Wayne Neurological Center (J.C.S.), Fort Wayne, IN; and Elkhart Clinic (T.R.V.), Elkhart, IN.
  1. Correspondence to Mr. Dall: tim.dall{at}ihs.com
View Full Text

Article usage

Article usage: April 2013 to February 2023

AbstractFullPdfSource
Apr 20138850214Highwire
May 20133640210Highwire
Jun 2013245060Highwire
Jul 201398425173Highwire
Aug 201394852155Highwire
Sep 2013371535Highwire
Oct 2013362626Highwire
Nov 2013247414Highwire
Dec 201320219Highwire
Jan 2014230717Highwire
Feb 2014184614Highwire
Mar 20142371722Highwire
Apr 201418735Highwire
May 2014236710Highwire
Jun 20141681012Highwire
Jul 2014140718Highwire
Aug 2014106211Highwire
Sep 2014125614Highwire
Oct 201416128Highwire
Nov 201413389Highwire
Dec 201411226Highwire
Jan 2015137711Highwire
Jan 201502814pmc
Feb 201512424Highwire
Feb 201501611pmc
Mar 201513729Highwire
Mar 201501811pmc
Apr 201512524Highwire
Apr 20150248pmc
May 201515436Highwire
May 201504211pmc
Jun 201520524Highwire
Jun 201503511pmc
Jul 201515723Highwire
Jul 201504110pmc
Aug 201516829Highwire
Aug 20150378pmc
Sep 2015149110Highwire
Sep 201507710pmc
Oct 201514626Highwire
Oct 201506912pmc
Nov 2015169611Highwire
Nov 201506117pmc
Dec 201515134Highwire
Dec 20150636pmc
Jan 2016157312Highwire
Jan 201608221pmc
Feb 201610825Highwire
Feb 20160897pmc
Mar 201614027Highwire
Mar 201609922pmc
Apr 201614628Highwire
Apr 2016013525pmc
May 201614596Highwire
May 2016011814pmc
Jun 201614034Highwire
Jun 2016013021pmc
Jul 201610565Highwire
Jul 2016016722pmc
Aug 201611547Highwire
Aug 201601486pmc
Sep 201612435Highwire
Sep 2016019617pmc
Oct 201613445Highwire
Oct 2016016512pmc
Nov 201611128Highwire
Nov 2016016824pmc
Dec 20169216Highwire
Dec 2016012230pmc
Jan 201711825Highwire
Jan 2017014912pmc
Feb 201711779Highwire
Feb 2017023624pmc
Mar 201710148Highwire
Mar 2017023722pmc
Apr 2017138214Highwire
Apr 201717207221pmc
May 20176724Highwire
May 201722206225pmc
Jun 20178512Highwire
Jun 201714133160pmc
Jul 20177635Highwire
Jul 201717172200pmc
Aug 20176601Highwire
Aug 201723206225pmc
Sep 201710224Highwire
Sep 201726237276pmc
Oct 20179976Highwire
Oct 201723257303pmc
Nov 20177353Highwire
Nov 201724287330pmc
Dec 201710001Highwire
Jan 20189396Highwire
Feb 2018104106Highwire
Mar 201811332Highwire
Apr 20187241Highwire
Apr 201819254283pmc
May 20186554Highwire
Jun 20185242Highwire
Jun 201819188216pmc
Jul 20187343Highwire
Aug 20186766Highwire
Aug 201811206252pmc
Sep 20185864Highwire
Oct 20188274Highwire
Nov 201868126Highwire
Dec 20187675Highwire
Jan 201967118Highwire
Feb 20197874Highwire
Mar 20196348Highwire
Apr 201910386Highwire
May 20197068Highwire
Jun 20196037Highwire
Jul 201990106Highwire
Aug 201985107Highwire
Sep 20196757Highwire
Oct 20198585Highwire
Nov 201912552Highwire
Dec 20194181Highwire
Jan 20209374Highwire
Feb 202063102Highwire
Mar 20207671Highwire
Apr 20207462Highwire
May 202014074Highwire
Jun 20206122Highwire
Jul 20205310Highwire
Aug 20208135Highwire
Sep 202011498Highwire
Oct 2020119173Highwire
Nov 20209771Highwire
Dec 202082157Highwire
Jan 2021114217Highwire
Feb 202160183Highwire
Mar 202196203Highwire
Apr 202179114Highwire
May 2021101284Highwire
Jun 2021132109Highwire
Jul 2021109214Highwire
Aug 2021101175Highwire
Sep 2021105111Highwire
Oct 2021103152Highwire
Nov 20219272Highwire
Dec 20218884Highwire
Jan 2022145138Highwire
Feb 202210231Highwire
Mar 202214662Highwire
Apr 20221202115Highwire
May 2022123217Highwire
Jun 202211875Highwire
Jul 202212053Highwire
Aug 2022107149Highwire
Sep 202293155Highwire
Oct 2022192124Highwire
Nov 2022142266Highwire
Dec 2022101143Highwire
Jan 2023160254Highwire
Feb 2023120232Highwire

Cited By...

Letters: Rapid online correspondence

  • Re:Overestimate of Neurology Workforce
    • Timothy M Dall, Health Economist, IHS Healthare & Pharma
    • Tim Dall, Washington DC; Oksana Drogan, Atlanta, GA
    Submitted February 19, 2014
  • Overestimate of Neurology Workforce
    • Brad A. Racette, M.D., FAAN, Professor and Vice Chairman of Neurology, Washington University School of Medicine
    • David M. Holtzman, M.D., FAAN, Professor and Chairman of Neurology, St. Louis, MO
    Submitted November 02, 2013
  • Impact of Subspecialization
    • Trent S. Hodgson, Medical Student, University of Chicago Pritzker School of Medicine
    • Trent S. Hodgson, Chicago, IL; Rimas V. Lukas, Chicago, IL
    Submitted August 14, 2013
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles

  • Contemporary Issues
    The Workforce Task Force Report
    Clinical implications for neurology
    William D. Freeman, Kenneth A. Vatz, Robert C. Griggs et al.
    Neurology, June 19, 2013
  • Contemporary Issues
    Specialty care by child neurologists
    A workforce analysis
    D. Polsky, J. Weiner, J. F. Bale, Jr et al.
    Neurology, March 21, 2005
  • Special Article
    Neurology in the next two decades
    Report of the Workforce Task Force of the American Academy of Neurology
    Walter G. Bradley et al.
    Neurology, February 22, 2000
  • Contemporary Issues
    The coming crisis
    Obtaining care for the growing burden of neurodegenerative conditions
    E. Ray Dorsey, Benjamin P. George, Bruce Leff et al.
    Neurology, April 24, 2013